GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » FCF Yield %

NKGen Biotech (NKGen Biotech) FCF Yield % : -19.30 (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NKGen Biotech's Trailing 12-Month Free Cash Flow is $-5.47 Mil, and Market Cap is $28.34 Mil. Therefore, NKGen Biotech's FCF Yield % for today is -19.30%.

The historical rank and industry rank for NKGen Biotech's FCF Yield % or its related term are showing as below:

NKGN' s FCF Yield % Range Over the Past 10 Years
Min: -68.73   Med: 0   Max: 0
Current: -19.3


NKGN's FCF Yield % is ranked worse than
57.78% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs NKGN: -19.30

NKGen Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


NKGen Biotech FCF Yield % Historical Data

The historical data trend for NKGen Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech FCF Yield % Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -36.54

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Sep23 Dec23
FCF Yield % - - - - -

Competitive Comparison of NKGen Biotech's FCF Yield %

For the Biotechnology subindustry, NKGen Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKGen Biotech's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's FCF Yield % falls into.



NKGen Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NKGen Biotech's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-21.996 / 60.19475
=-36.54%

NKGen Biotech's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 60.19475
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKGen Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


NKGen Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.